TherageniX and University of Nottingham awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

Bax­ter In­ter­na­tion­al and Take­da agreed to pay $42.7 mil­lion Tues­day to set­tle with the Texas at­tor­ney gen­er­al over al­le­ga­tions that the com­pa­nies paid clin­i­cians to

LONDON — No blanket statement could be made regarding whether patients undergoing noncardiac surgery should continue or withdraw their renin-angiotensin system (RAS) inhibitor therapy based